"Designing Growth Strategies is in our DNA"
Cell lysis is a method in which the cell membrane or cell membrane is broken down or destroyed to release inter-cellular materials such as protein, DNA, RNA, or organelles from a cell. It is an important unit operation for, immunoassays for point-of-care diagnostics, molecular diagnostics of pathogens, down-streaming process such as protein purification for studying protein structure and function, drug screening, cancer diagnostics, and analysis of the composition of specific proteins, lipids, and nucleic acids individually or as complexes. Increasing government funding for cell-based research and development, rising prevalence of diseases, expanding biotechnology and biopharmaceutical companies, new product launches by the major players are some of the factors that are expected to augment the market growth during the forecast period. For instance, in April 2018, BD launched BD FACSymphony S6 cell sorter intending to give researchers the ability to sort cell populations to better understand cell phenotypes for immunology and multi-omics research
Increasing government funding for cell-based research and development, rising prevalence of diseases, expanding biotechnology and biopharmaceutical companies are some of the factors that are driving the market growth.
However, high costs associated with cell lysis and lack of enough skilled personnel are likely to decline the growth of the cell lysis market.
Key Market Driver -
Rising prevalence of contagious disease, increasing research and development spending
Key Market Restraint -
High costs associated with cell lysis, lack of enough skilled personnel
By product type, the market can be segmented into instruments and reagents & consumables. By instruments, the market can be further segmented into high-pressure homogeniser, sonicator, french press, microfluidizer, bead mill, and others. By cell type, the market can be segmented into mammalian cells, plant cells, bacterial cells, and others (yeast/algae/fungi). By application, the market can be segmented into protein isolation, cell organelle isolation, nucleic acid isolation, and others. By end users, the market can be segmented into academics & research institutes, hospitals & diagnostic labs, pharmaceutical & biotechnology companies, and others.
Geographically, the cell lysis market can be segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.
The major companies in the global cell lysis market report includes Bio-Rad Laboratories, Inc., Beckman Coulter, Inc., BD, Cell Signaling Technology, Inc., QIAGEN, F. Hoffmann-La Roche Ltd, and other prominent players.
The global cell lysis market is expected to be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is anticipated to have the largest market share due to increasing government initiatives and funding investment in molecular biology research, cancer research which are expected to impel the global cell lysis market. The market in Europe is likely to have substantial growth throughout the forecast period owing to the rising geriatric population, and rising prevalence of diseases. Asia Pacific and Latin America are expected to register fast market growth during the forecast period due to the increasing number of chronic diseases (cancer), and improved healthcare facilities. On the other hand, the Middle East and Africa is projected to have a lucrative growth in the cell lysis market in the upcoming years.
To gain extensive insights into the market, Request for Customization
ATTRIBUTE | DETAILS |
By Product Type |
|
By Cell Type |
|
By Application |
|
By End-User |
|
By Geography |
|
US +1 833 909 2966 ( Toll Free )